Targeting SMAD7 in Crohn's Disease by Mongersen: Therapeutic Revolution Under Way?

Gastroenterology

Volumn 149, Issue 4, 2015, Pages 1121-1123

  Danese, Silvio ^a   Fiorino, Gionata ^a   Peyrin Biroulet, Laurent ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 8; MONGERSEN; SMAD7 PROTEIN; TUMOR NECROSIS FACTOR; IMMUNOSUPPRESSIVE AGENT; OLIGONUCLEOTIDE;

ADULT; AGED; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HUMAN; MULTICENTER STUDY (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; SHORT SURVEY; ANTAGONISTS AND INHIBITORS; FEMALE; MALE;

CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OLIGONUCLEOTIDES; SMAD7 PROTEIN;

EID: 84942346066     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.08.023     Document Type: Note

References (0)